Infection with Helicobacter pylori cagA-positive strains is associated with gastric adenocarcinoma. Intestinal metaplasia is a precancerous lesion of the stomach characterized by transdifferentiation of the gastric mucosa to an intestinal phenotype. The H. pylori cagA gene product, CagA, is delivered into gastric epithelial cells, where it undergoes tyrosine phosphorylation by Src family kinases. Tyrosine-phosphorylated CagA specifically binds to and activates SHP-2 phosphatase, thereby inducing cell-morphological transformation. We report here that CagA physically interacts with E-cadherin independently of CagA tyrosine phosphorylation. The CagA/E-cadherin interaction impairs the complex formation between E-cadherin and b-catenin, causing cytoplasmic and nuclear accumulation of b-catenin. CagA-deregulated b-catenin then transactivates b-catenin-dependent genes such as cdx1, which encodes intestinal specific CDX1 transcription factor. In addition to b-catenin signal, CagA also transactivates p21 WAF1/Cip1 , again, in a phosphorylation-independent manner. Consequently, CagA induces aberrant expression of an intestinal-differentiation marker, goblet-cell mucin MUC2, in gastric epithelial cells that have been arrested in G1 by p21
Infection with Helicobacter pylori cagA-positive strains is associated with gastric adenocarcinoma. Intestinal metaplasia is a precancerous lesion of the stomach characterized by transdifferentiation of the gastric mucosa to an intestinal phenotype. The H. pylori cagA gene product, CagA, is delivered into gastric epithelial cells, where it undergoes tyrosine phosphorylation by Src family kinases. Tyrosine-phosphorylated CagA specifically binds to and activates SHP-2 phosphatase, thereby inducing cell-morphological transformation. We report here that CagA physically interacts with E-cadherin independently of CagA tyrosine phosphorylation. The CagA/E-cadherin interaction impairs the complex formation between E-cadherin and b-catenin, causing cytoplasmic and nuclear accumulation of b-catenin. CagA-deregulated b-catenin then transactivates b-catenin-dependent genes such as cdx1, which encodes intestinal specific CDX1 transcription factor. In addition to b-catenin signal, CagA also transactivates p21 WAF1/Cip1 , again, in a phosphorylation-independent manner. Consequently, CagA induces aberrant expression of an intestinal-differentiation marker, goblet-cell mucin MUC2, in gastric epithelial cells that have been arrested in G1 by p21 WAF1/Cip1 Introduction Infection with Helicobacter pylori strains carrying the cag pathogenicity island (cag PAI), which contains 31 putative genes, including cagA and those encoding components of a bacterial type IV secretion system, increases the risk for gastric adenocarcinoma compared with the risk incurred by cagA-negative strains Parsonnet et al., 1997) . The cagA gene product CagA is delivered into H. pylori-attached gastric epithelial cells via the type IV secretion system (Segal et al., 1999; Odenbreit et al., 2000) . Upon tyrosine phosphorylation by Src family kinases, CagA binds and activates SHP-2 tyrosine phosphatase to induce an elongated cell shape termed the 'hummingbird phenotype' (Higashi et al., 2002 (Higashi et al., , 2004 . CagA also interacts with and deregulates a number of cellular proteins such as Grb2, c-Met and ZO-1 in a phosphorylation-independent manner (Mimuro et al., 2002; Amieva et al., 2003; Churin et al., 2003) . These CagAhost protein interactions may collectively contribute to the development of gastric carcinoma (Hatakeyama, 2004) .
Gastric adenocarcinoma is subdivided into intestinal and diffuse types. Intestinal-type carcinoma arises from gastric mucosa with intestinal metaplasia, a pathological change characterized by the transdifferentiation of gastric progenitor cells into those committed to intestinal cell lineage, which is highly associated with infection with H. pylori cagA-positive strains (Kuipers et al., 1995; Sozzi et al., 1998) . Recent studies have shown that deregulation of b-catenin signal is involved in the pathological transdifferentiation of various cell lineages, including intestinal metaplasia (Bailey et al., 1998; Miyoshi et al., 2002; Bierie et al., 2003; Okubo and Hogan, 2004) . b-Catenin is localized to cell-cell junctions by interaction with the cytoplasmic tail of a transmembrane protein E-cadherin. The E-cadherin/ b-catenin complex plays a crucial role in epithelial cellcell interaction and in the maintenance of the normal architecture of epithelial tissues (Takeichi, 1991) . This complex also plays a role in canonical Wnt signaling, which regulates growth and differentiation of many cell types (Wang and Wynshaw-Boris, 2004) .
Deregulation of b-catenin plays a critical role in colorectal carcinogenesis (Giles et al., 2003) . Several lines of evidence also suggest the involvement of Ecadherin/catenin complex in gastric carcinogenesis. Germ line E-cadherin mutation is responsible for the development of hereditary diffuse-type gastric carcinoma (Guilford et al., 1998) , and somatic mutations in the E-cadherin or b-catenin gene have been reported in sporadic gastric carcinoma (Berx et al., 1998) . We recently reported that in vivo adaptation of cagApositive H. pylori enhances its carcinogenic potential in a rodent model (Franco et al., 2005) . Intriguingly, the oncogenic H. pylori strain activates the b-catenin signal in gastric epithelial cells in a CagA-dependent manner. However, the mechanism through which CagA deregulates b-catenin remained to be elucidated. Here, we show that CagA interacts with E-cadherin and impairs the E-cadherin/b-catenin complex, resulting in deregulated activation of b-catenin signal that induces intestinal-specific genes in gastric epithelial cells. We discuss our results in the context of intestinal metaplasia, a premalignant gastric mucosal lesion.
Results
Activation of b-catenin by CagA independent of tyrosine phosphorylation To investigate the mechanism by which CagA deregulates b-catenin, we performed a luciferase reporter assay of b-catenin signaling using MKN28 and MKN45 human gastric epithelial cell lines, both of which express E-cadherin and show a strict membrane localization of b-catenin at the cell-cell contact sites (data not shown). We co-transfected a gene encoding hemagglutinin (HA)-tagged wild-type CagA (WT-CagA) or an HA-tagged phosphorylation-resistant CagA mutant (PR-CagA) together with the TOPtkLuciferase reporter that responds to b-catenin signal or the control FOPtkLuciferase in these cells. TOPtkLuciferase but not FOPtk Luciferase was markedly activated upon expressing of WT-CagA or PR-CagA in both cells (Figure 1a) . TOPtkLuciferase activation by CagA was abolished by co-expression of APC tumor suppressor protein, which promotes b-catenin degradation (Figure 1a) . CagA also transactivated the b-catenin-dependent cyclin D1 promoter in a luciferase reporter assay and this promoter activation was, again, abolished by co-expression of APC (Figure 1a) . Accordingly, CagA stimulates b-catenin signal in a manner independent of CagA phosphorylation.
Cytoplasmic/nuclear accumulation of b-catenin by CagA in gastric epithelial cells The b-catenin signal can be activated either through relocalization of b-catenin or increased stability of b-catenin. To investigate these two possibilities, we established MKN28-derived stable transfectant clones that inducibly express HA-tagged WT-CagA (clones WT-A10 and WT-D11) or HA-tagged PR-CagA (clones PR-C2 and PR-C10) under a tetracycline-regulated (tetoff) system (Figure 1b) . In WT-A10 or PR-C10 cells without CagA induction, b-catenin was strictly localized to cell-cell contact sites. In contrast, a significant fraction of WT-A10 or PR-C10 cells expressing WTCagA or PR-CagA showed cytoplasmic/nuclear staining of b-catenin ( Figure 1c ). As these results were obtained by transfection of the cagA gene, we next investigated the effect of CagA on b-catenin signaling upon H. pylori infection. Infection of MNK28 cells with cagA-positive H. pylori, but not with cagA-negative H. pylori, caused cytoplasmic/nuclear accumulation of b-catenin (Figure 1d and e). Notably, the levels of infected CagA were comparable to those of transiently transfected CagA in MKN28 cells. These results indicate that CagAmediated b-catenin translocalization is a pathophysiologically relevant phenomenon. To consolidate this observation, MKN28 cells were transiently transfected with an HA-tagged CagA expression vector and were double-stained with anti-HA and anti-b-catenin antibodies. Transverse sections of the stained MKN28 Association of CagA with E-cadherin b-Catenin is localized to the membrane at cell-cell contact sites by interacting with the cytoplasmic tail of E-cadherin. Accordingly, we investigated the possibility that membrane-associated CagA physically associates with E-cadherin and thereby impairs the E-cadherin/ b-catenin interaction. To this end, we immunoprecipitated HA-tagged WT-or PR-CagA with anti-HA antibody from lysates of WT-A10 or PR-C2 cells. The immunoprecipitates were then immunoblotted with an anti-E-cadherin antibody. The results of the experiment revealed that E-cadherin is physically associated with both WT-and PR-CagA (Figure 2a) . Consistently, treatment of CagA-expressing WT-A10 cells with PP2, a specific inhibitor of Src family kinases, significantly reduced the level of CagA tyrosine phosphorylation but did not affect the complex formation between CagA and E-cadherin (Supplementary Figure S1) . Thus, CagA interacts with E-cadherin in a tyrosine phosphorylationindependent manner. Importantly, the CagA/E-cadherin complex failed to pull down b-catenin ( Figure Deregulation of b-catenin signal by CagA N Murata-Kamiya et al ( Figure 3a) . CagA was detectable in cells 6 h after the depletion of doxycycline (Dox) from the culture. Cyclin D1 began to be induced around 24 h after the CagA induction (Figure 3a and b) , which was concordant with the cytoplasmic/nuclear accumulation of b-catenin (Figure 1c) . Notably, detection of CagA at 6 h was almost immediately followed by an increase in p21
(hereafter designated as p21) (Figure 3a and b) . CagA has been recently shown to stimulate the calcineurinnuclear factor of activated T cells (NFAT) pathway, which induces p21, in AGS human gastric epithelial cells (Yokoyama et al., 2005) . Consistently, treatment of WT-A10 cells with cyclosporin A, a specific inhibitor of calcineurin, significantly inhibited CagA-mediated p21 accumulation, as was the case in AGS cells ( Figure S2 ). Thus, activation of NFAT by CagA is involved at least partly in the induction of p21 as reported previously. Induction of p21 and cyclin D1 was also reproduced when PR-CagA was inducibly expressed in PR-C10 cells (data not shown). Unexpectedly, CagA inhibited rather than activated the expression of c-Myc (data not shown), which has been reported as one of the Wnt targets (He et al., 1998) . In this regard, recent studies indicate that the effect of the b-catenin signal on the expression of bcatenin target genes is cell context-dependent and indeed c-myc has been shown to be inhibited by the b-catenin signal in certain cellular settings (Johnston and Edgar, 1998; Duman-Scheel et al., 2004) . To consolidate activation of the b-catenin signal by CagA, WT-A10 cells were cultured in the presence or absence of Dox and, at 36 h after onset of CagA induction, total RNAs were isolated and were subjected to a genome-wide cDNA microarray analysis. Among genes upregulated by CagA were p21, cyclin D1 and several other b-catenindependent genes such as ECM1 and Neurotensin receptor 1 (Kenny et al., 2005; Souaze´et al., 2006) . Sequential induction of p21 and cyclin D1 by CagA indicated that the bacterial protein generates both growth-inhibitory and growth-stimulatory signals in a single cell. Accordingly, we next investigated the effect of CagA on the growth of MKN28 and found that inducible expression of WT-or PR-CagA causes G1 arrest (Figure 4 and Supplementary Figure S3) . Hence, p21 exerts a dominant effect over cyclin D1 on the growth of gastric epithelial cells expressing CagA.
Induction of intestinal transdifferentiation in gastric epithelial cells by CagA
Execution of the cell differentiation program requires G1 cell-cycle arrest. As CagA causes G1-arrest by inducing p21 and at the same time deregulates the Deregulation of b-catenin signal by CagA N Murata-Kamiya et al b-catenin signal, which is reportedly involved in intestinal metaplasia (Bailey et al., 1998; Okubo and Hogan, 2004) , we next addressed the issue of whether CagA is capable of conferring transdifferentiation of gastric epithelial cells. To this end, WT-A10 cells were cultured in the presence or absence of Dox. After 14 days culture, RNAs isolated were subjected to a genome-wide cDNA microarray analysis. RNA from WT-A10 cells serum-starved for 14 days without CagA was employed as a control RNA. Among genes upregulated by CagA, those that were not induced by serum starvation were selected. Selected genes included p21 and cyclin D1 and also b-catenin-dependent genes such as L1 cell adhesion molecule, cyclin D2 and cdx1 (Lickert et al., 2000; Kioussi et al., 2002; Gavert et al., 2005) (Table 1) . Transactivation of the cdx1 promoter by CagA was also confirmed by a luciferase reporter assay (Supplementary Figure S4) . Furthermore, cdx1 mRNA was detectable in CagA-induced WT-A10 cells, whereas it was hardly detectable in uninduced WT-A10 cells (Figure 5a ). In contrast, we could not detect another intestinal-specific transactivator gene cdx2 in WT-A10 cells by CagA in the cDNA microarray analysis. Since the cdx1 gene product CDX1 is a transcription factor that plays a crucial role in intestinal differentiation, WT-A10 or PR-C10 cells were growtharrested by CagA or serum starvation and were immunostained with an antibody against goblet-cell mucin MUC2, a specific marker for intestinal differentiation (Mizoshita et al., 2004) . MUC2 was detectable in cells expressing WT-or PR-CagA but not in G1-arrested cells without CagA induction (Figure 5b ). These results indicated that activation of b-catenin signal in growth-arrested gastric epithelial cells is involved in the induction of intestinal-specific molecules.
Induction of MUC2 by ectopic co-expression of p21 and constitutively active b-catenin To consolidate the above observation, we established MKN28-derived stable transfectants that inducibly express p21, b-catenin (S33Y) or both p21 and b-catenin (S33Y) under a tet-off system (Figure 5c ). These transfectants were cultured in the presence or absence of Dox for 14 days and then stained with anti-MUC2. MUC2 was detectable in MKN28 cells co-expressing p21 and b-catenin (S33Y), but not in MKN28 cells singly expressing either p21 or b-catenin (S33Y) (Figure 5c ). Thus, the b-catenin signal in conjunction with p21-mediated G1-arrest is both necessary and sufficient for induction of intestinal-specific molecules in gastric epithelial cells. Consistently, DNA microarray analysis revealed that CagA also upregulates intestinal-specific genes such as intestinal cell kinase and an intestine crypt transcription factor SOX9 (Table 1) (Togawa et al., 2000; Blache et al., 2004) . Among genes transcriptionally upregulated by CagA, those that unchanged by serum starvation are picked up. The change in expression level is indicated as log 2 ratio of the fold change vs the expression level of uninduced cell.
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Discussion
In this work, we demonstrated that CagA interacts with E-cadherin in a manner independent of CagA tyrosine phosphorylation and causes destabilization of the Ecadherin/b-catenin complex, resulting in cytoplasmic/ nuclear accumulation of b-catenin. Although the details of the CagA/E-cadherin interaction remain to be elucidated, CagA might directly inhibit the complex formation between E-cadherin and b-catenin by competing with b-catenin for E-cadherin binding. Alternatively, CagA might be indirectly connected to E-cadherin via another component of the apical-junctional complex and this nonphysiological connection destabilizes the E-cadherin/b-catenin complex. CagAderegulated b-catenin then induces intestinal-specific genes in gastric epithelial cells. Our study revealed molecular mechanisms by which cagA-positive H. pylori induces cytoplasmic/nuclear accumulation of b-catenin as reported previously (Franco et al., 2005) . In contrast to our results, Bebb et al. (2006) recently reported that infection of HT29 colon carcinoma cells with H. pylori (either cagA-positive or cagA-negative strain) led to a reduction in junctional expression of b-catenin without any increase in cytoplasmic or nuclear immunostaining. Unfortunately, the work did not provide experimental data that show translocation of CagA from H. pylori into HT29 cells, raising a possibility that H. pylori failed to deliver sufficient amounts of CagA into the host cells in their infection experiment. Our work provides a molecular insight into the role of cagA-positive H. pylori in the pathological sequence during intestinal-type gastric carcinoma development. Chronic infection with H. pylori cagA-positive strains leads to atrophic gastritis, which is characterized by the continuous loss of gastric glands. We demonstrated that CagA transactivates p21 in gastric epithelial cells at least in part through activation of NFAT as described previously (Yokoyama et al., 2005) . The elevated p21 causes G1 cell-cycle arrest. In addition, impaired cellcell interaction by CagA may destroy normal gastric mucosal architecture and potentiate local inflammation at the sites of H. pylori infection. These CagA activities collectively increase cell turnover by stimulating both apoptosis and compensatory cell proliferation, which underlies the development of atrophic gastritis and at the same time accelerates acquisition of mutations in tumor-related genes in gastric epithelial cells. Atrophic gastritis is associated with intestinal metaplasia, a premalignant lesion in which normal gastric mucosa is replaced by intestinal-type epithelial cells (Kuipers et al., 1995; Sozzi et al., 1998) . Recent studies have revealed that deregulated b-catenin signal induces transdifferentiation of cells from one lineage to another. For example, forced activation of b-catenin in mammary epithelial or prostate epithelial cells results in development of squamous metaplasia (Miyoshi et al., 2002; Bierie et al., 2003) . Furthermore, expression of a constitutively active b-catenin-Lef1 fusion protein in the mouse lung induces transdifferentiation of lung epithelial cells to intestinal-type cells (Okubo and Hogan, 2004) . Our microarray analysis also revealed that CagA activates b-catenin-dependent genes that are involved in intestinal differentiation. One of those CagA-activated genes is cdx1, which encodes CDX1 transcription factor (Lickert et al., 2000) . CDX1 and CDX2 are specifically expressed in the intestine, where they play a crucial role in the regulation of cell proliferation and differentiation (Guo et al., 2004) . Aberrant expression of CDX1 is found in areas of the stomach and esophagus containing intestinal metaplasia (Silberg et al., 1997) and transgenic expression of CDX1 in mouse stomach induces intestinal metaplasia (Mutoh et al., 2004) . Thus, CagA-induced CDX1 may play a role in the transdifferentiation of gastric mucosa to an intestinal type. Indeed, induction of CDX1 by CagA-activated b-catenin is associated with ectopic expression of intestinal differentiation marker MUC2 in gastric epithelial cells. With regard to this, expression of a constitutively active b-catenin in exponentially proliferating gastric epithelial cells per se failed to induce MUC2, whereas co-expression of the constitutively active b-catenin together with p21 resulted in MUC2 expression (Figure 5c ). Accordingly, p21-caused G1-cell cycle arrest may also be necessary to turn on the intestinal differentiation program by the deregulated b-catenin in gastric epithelial cells expressing CagA.
b-Catenin signal also plays a crucial role in cell proliferation as well as cell transformation. Blocking of the b-catenin signal in the intestine results in inhibition of the proliferation of intestinal cells, whereas deregulated b-catenin signaling plays a critical role in colon carcinogenesis (Giles et al., 2003; Pinto et al., 2003) . More recently, we reported that deregulation of the b-catenin signal by CagA is associated with enhanced carcinogenic potential of cagA-positive H. pylori in a rodent model (Franco et al., 2005) . CagA-activated b-catenin induces cyclin D1 in gastric epithelial cells. However, the growth-promoting activity of elevated cyclin D1 is counteracted by p21, which is simultaneously induced by CagA. The dominant effect of p21 over cyclin D1 on the cell cycle, which causes G1 arrest, may be required for the transdifferentiation of gastric epithelial cells by the CagA-activated b-catenin signal. This in turn raises a possibility that any genetic/ epigenetic changes that downregulate p21 levels confer growth advantage to the CagA-expressing cells with elevated cyclin D1 and CagA-deregulated SHP-2.
In conclusion, we provide the first molecular link between H. pylori CagA and multistep gastric carcinogenesis. Association of CagA with E-cadherin, which results in impaired cell-cell interaction and at the same time deregulated activation of b-catenin signal, may play an important role in promoting pathological changes that precede transformation of gastric epithelial cells.
Materials and methods

Antibodies
Antibodies for HA (Y-11), SHP-2 (C-18), cyclin D1 (H-295), anti-p21 WAF1/Cip1 (C-19), E-cadherin (G-10), mucin 2 (MUC2) (Ccp58) and b-catenin (H-102) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-b-catenin antibody was from Transduction Laboratories (San Diego, CA, USA). Antiphosphotyrosine antibody (4G10) was from Upstate Biotechnology (Lake Placid, NY, USA). Anti-FLAG M2 antibody was from SIGMA (St Louis, MO, USA). AntiCagA antibody was from AUSTRAL Biologicals (San Ramon, CA, USA). Anti-Bromodeoxyuridine antibody and anti-HA rat antibody (3F10) were from Roche (Mannheim, Germany).
Expression vectors
The cagA gene was isolated from H. pylori strain NCTC11637. pSP65SRa-WT-CagA and pSP65SRa-PR-CagA were described previously (Higashi et al., 2002) . TOPtkLuciferase and FOPtkLuciferase plasmids were described previously (Tago et al., 2000) .
Cell culture and transfection MKN28 and MKN45 human gastric epithelial cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). Cells were transfected with plasmids using Lipofectamine reagent (Invitrogen, Carlsbad, CA, USA) or TransFectin Lipid Reagent (Bio-Rad, Hercules, CA, USA) according to the manufacturers' instructions. MKN28(tet-off) cells (Clontech, Palo Alto, CA, USA) were cultured in RPMI 1640 medium supplemented with 10% FBS, 0.5 mg/ml G418 and 1 mg/ml Dox.
Luciferase reporter assay Luciferase activities were measured using the dual luciferase assay kit (Promega, Madison, WI, USA), according to the manufacturer's instructions. Luciferase activity was normalized by the pRL-TK luciferase activity.
Immunoprecipitation and immunoblotting
Cells were lysed in Lysis buffer T (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM ethylenediaminetetraacetic acid, 1% Triton X-100, 10% glycerol, 2 mM Na 3 VO 4 , 10 mM NaF, 10 mM b-glycerophosphate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml trypsin inhibitor and 2 mM phenylmethylsulfonyl fluoride). Immunoprecipitation and immunoblotting were performed as described previously (Higashi et al., 2004) .
Microarray analysis
Total RNAs were extracted from the cells using Trizol reagent (Invitrogen) and were processed according to the protocol recommended by Affymetrix (Santa Clara, CA, USA). In all, 5 mg of labeled cRNA from each sample was hybridized to the Deregulation of b-catenin signal by CagA N Murata-Kamiya et al human genome U133A Plus 2.0 Array GeneChip (Affymetrix) representing approximately 38 500 genes. The data output of GeneChip was normalized and analysed using Affymetrix GeneChip Operating Software version 1.1. The raw GeneChip data were transformed into log format following the recommendation by Affymetrix (Knudsen, 2002) .
